247 related articles for article (PubMed ID: 20513592)
1. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time?
Rudd JH; Narula J; Strauss HW; Virmani R; Machac J; Klimas M; Tahara N; Fuster V; Warburton EA; Fayad ZA; Tawakol AA
J Am Coll Cardiol; 2010 Jun; 55(23):2527-35. PubMed ID: 20513592
[TBL] [Abstract][Full Text] [Related]
2. FDG PET imaging and cardiovascular inflammation.
Hiari N; Rudd JH
Curr Cardiol Rep; 2011 Feb; 13(1):43-8. PubMed ID: 20949379
[TBL] [Abstract][Full Text] [Related]
3. Should vascular wall
Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases.
Miyagawa M; Yokoyama R; Nishiyama Y; Ogimoto A; Higaki J; Mochizuki T
Circ J; 2014; 78(6):1302-10. PubMed ID: 24817762
[TBL] [Abstract][Full Text] [Related]
5. Vascular imaging with positron emission tomography.
Joshi F; Rosenbaum D; Bordes S; Rudd JH
J Intern Med; 2011 Aug; 270(2):99-109. PubMed ID: 21518037
[TBL] [Abstract][Full Text] [Related]
6. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
7. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.
Rudd JH; Myers KS; Bansilal S; Machac J; Rafique A; Farkouh M; Fuster V; Fayad ZA
J Am Coll Cardiol; 2007 Aug; 50(9):892-6. PubMed ID: 17719477
[TBL] [Abstract][Full Text] [Related]
8. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
[TBL] [Abstract][Full Text] [Related]
9. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
Rudd JH; Myers KS; Bansilal S; Machac J; Woodward M; Fuster V; Farkouh ME; Fayad ZA
Circ Cardiovasc Imaging; 2009 Mar; 2(2):107-15. PubMed ID: 19808576
[TBL] [Abstract][Full Text] [Related]
10. Targeted PET/CT imaging of vulnerable atherosclerotic plaques: microcalcification with sodium fluoride and inflammation with fluorodeoxyglucose.
Chen W; Dilsizian V
Curr Cardiol Rep; 2013 Jun; 15(6):364. PubMed ID: 23605466
[TBL] [Abstract][Full Text] [Related]
11. Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.
Kai H
Geriatr Gerontol Int; 2010 Jan; 10(1):1-8. PubMed ID: 20102376
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.
Tahara N; Kai H; Ishibashi M; Nakaura H; Kaida H; Baba K; Hayabuchi N; Imaizumi T
J Am Coll Cardiol; 2006 Nov; 48(9):1825-31. PubMed ID: 17084257
[TBL] [Abstract][Full Text] [Related]
13. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
Brammen L; Steiner S; Berent R; Sinzinger H
Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET imaging of atherosclerosis: Do we know what we see?
Sheikine Y; Akram K
Atherosclerosis; 2010 Aug; 211(2):371-80. PubMed ID: 20202637
[TBL] [Abstract][Full Text] [Related]
15. [¹⁸F]-fluorodeoxyglucose PET imaging of atherosclerosis.
Blomberg BA; Høilund-Carlsen PF
PET Clin; 2015 Jan; 10(1):1-7. PubMed ID: 25455876
[TBL] [Abstract][Full Text] [Related]
16. (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation.
Chen W; Dilsizian V
Curr Cardiol Rep; 2010 Mar; 12(2):179-84. PubMed ID: 20425174
[TBL] [Abstract][Full Text] [Related]
17. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
Kang WJ
Korean J Radiol; 2015; 16(6):1257-61. PubMed ID: 26576114
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging of coronary inflammation.
Pelletier-Galarneau M; Ruddy TD
Trends Cardiovasc Med; 2019 May; 29(4):191-197. PubMed ID: 30195945
[TBL] [Abstract][Full Text] [Related]
19. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
Tawakol A; Fayad ZA; Mogg R; Alon A; Klimas MT; Dansky H; Subramanian SS; Abdelbaky A; Rudd JH; Farkouh ME; Nunes IO; Beals CR; Shankar SS
J Am Coll Cardiol; 2013 Sep; 62(10):909-17. PubMed ID: 23727083
[TBL] [Abstract][Full Text] [Related]
20. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement.
Huet P; Burg S; Le Guludec D; Hyafil F; Buvat I
J Nucl Med; 2015 Apr; 56(4):552-9. PubMed ID: 25722452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
